Is CRBG's Q3 2024 earnings trend a concern?
4/13/2025 01:13pm
**Corebridge Financial's (CRBG) Q3 2024 earnings trend does raise concerns**, primarily due to the following factors:
1. **Significant Net Loss in Q3 2024**: CRBG reported a net loss of $1.19 billion for Q3 2024, with a diluted EPS of -$2.02. This is a stark contrast to the previous quarter's performance, where the company reported a net income of $365 million and operating EPS of $1.13.
|code|Ticker|Name|Date|Net Income YoY|Total Revenue YoY|Diluted EPS YoY|market_code|
|---|---|---|---|---|---|---|---|
|CRBG|CRBG.N|Corebridge Financial|2023 Q4|-692.2619047619047|-18.7696778881085||169|
|CRBG|CRBG.N|Corebridge Financial|2024 Q1|282.560706401766|36.93101830126701|301.42857142857144|169|
|CRBG|CRBG.N|Corebridge Financial|2024 Q2|-54.593874833555255|-35.55671356609345|-50|169|
|CRBG|CRBG.N|Corebridge Financial|2024 Q3|-157.37071048815855|-52.479564032697546|-161.58536585365854|169|
2. **Decline in Variable Investment Income**: The company experienced a decline in variable investment income due to alternative investments. This decline, coupled with other factors, contributed to the net loss in Q3 2024.
3. **Expected Loss in Variable Interest Entity**: CRBG anticipated a loss in its Variable Interest Entity (VIE) due to a bond call event, which is expected to impact Q3 2024 results. This adds to the uncertainty surrounding the quarter's earnings.
4. **Challenging Market Conditions**: The broader market environment, including interest rates and economic conditions, can significantly impact insurance and financial services companies like CRBG. The company's performance in Q3 2024 may be influenced by these external factors.
In conclusion, while CRBG has shown strong performance in the past, the company's Q3 2024 earnings trend indicates a challenging period. The significant net loss, decline in variable investment income, and expected loss in the VIE all point to a quarter that may not meet market expectations. Investors should monitor the company's performance closely and consider these factors when assessing CRBG's future prospects.